Crinetics.com
Acromegaly Expert Peter Trainer
WEBSAN DIEGO – November 16, 2020 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the appointment of Peter Trainer, MD, FRCPE to the position …
Actived: Just Now
URL: https://crinetics.com/acromegaly-expert-peter-trainer-vp-clinical-endocrinology/
Gina Ford Named VP Corporate Strategy, Commercial Planning
WEBSAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the appointment of Gina Ford, RPh, MBA, …
40th Annual J.P. Morgan Health Care Conference
WEBJan 12, 2022 at 4:30 PM EST. Scott Struthers, Ph.D., founder & CEO of Crinetics, will provide a company update at the 40th annual J.P. Morgan Healthcare Conference on Wednesday, January 12th at 4:30 PM Eastern Time / 1:30 PM Pacific Time. A live audio webcast of Dr. Struthers’ presentation may be accessed on the Events page of the …
Rare Disease Day 2022 Crinetics
WEBRare Disease Day is February 28. There are 300 million people world-wide living with a rare disease. That’s why Crinetics remains committed not only to raising awareness for rare endocrine diseases but also to developing more effective treatments and getting them to patients. So as we continue to new drug discovery for acromegaly, congenital
Crinetics Pharmaceuticals Awarded Up To $3.2 Million In …
WEBCrinetics Pharmaceuticals, Inc., today announced that it has been awarded up to approximately $3.2 million in Small Business Innovation Research (SBIR) grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to fund the continued research and development of its …
Crinetics Careers
WEBCrinetics offers comprehensive health, dental, vision benefits, ESPP plan at a discount, stock options, RSUs and 401k matching. In addition, we offer supplemental benefits that support physical, emotional, career and financial well-being. Learn about our benefits. Subscribe to get updates when we add new positions.
Crinetics ( $CRNX ) Closes Common Stock Public Offering
WEBSAN DIEGO – October 25, 2021 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that is has closed its previously announced underwritten …
CRN04894, Demonstrates Pharmacologic Proof-of-Concept
WEBCrinetics will hold a conference call and live audio webcast today, August 10, 2021 at 4:30 p.m. Eastern Time to discuss the results of the CRN04894 SAD cohorts. To participate, please dial 800-772-3714 (domestic) or 212-271-4615 (international) and refer to conference ID 21996541. To access the webcast, please visit the Events page on the
Alessandra Casagrande, M.D., Ph.D. Medical Sciences Director
WEBAlessandra Casagrande, M.D., Ph.D., Medical Sciences Director. “Neuroendocrinology has traditionally been an underserved discipline in that it doesn’t get the level of research funding many other disciplines do. I like that Crinetics recognized this from the start and pours so much effort and energy into making up for that.
Manager, Quality Control And Stability
WEBManage release testing and stability programs for various projects in preclinical and clinical development internally or at external parties. Author, review, and approve stability protocols; responsible for planning, execution, data management, data analysis, and data trending to support drug substance (API)/drug product retest period/shelf-life determination.
Director, Health Economics And Outcomes Research (Congenital …
WEBAdvanced degree related to health economics and/or health outcomes research (MSc, MPH, PhD, PharmD, RN, MD) Minimum of 10 years of relevant pharmaceutical/ consulting HEOR experience, plus a minimum of 8 years in a supervisory role
Crinetics To Highlight Broad Pipeline At ENDO 2023
WEBSAN DIEGO, June 9, 2023 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), (Nasdaq: CRNX) today announced upcoming presentations that will highlight the company’s pipeline at ENDO 2023, the Endocrine Society’s annual meeting, which is being held June 15-18, 2023 in Chicago, Illinois. Two presentations will provide additional clinical evidence and …
Discovery and Characterization of Orally Bioavailable …
WEBTitle: Suppression of Growth Hormone and Insulin-Like Growth Factor 1 in Rats After Oral Administration of CRN00808, a Small Molecule, sst2 Selective Somatostatin Biased Agonist Stephen F. Betz1, Stacy Markison1, Ana Karin Kusnetzow1, Jon D. Athanacio1, Elizabeth Rico-Bautista1, Ajay Madan1, Michael Johns1, Yun Fei Zhu1, Agnes Schonbrunn2, R. …
Senior Scientist 2, Metabolic Diseases
WEBPosition Summary: The Senior Scientist 2, Metabolic Diseases will be responsible for conducting mechanistic and differentiation studies critical to programs in obesity, diabetes, and related metabolic diseases.The candidate will also contribute significantly to new target identification and provide scientific contributions across metabolic disease programs.
41st Annual J.P. Morgan Healthcare Conference
WEB41st Annual JP Morgan Healthcare Conference. January 11, 2023 at 3:00 PM PST. Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, provided a company update at the annual J.P. Morgan Healthcare Conference, which took place in …
Crinetics Hosting Key Opinion Leader Webinar To Discuss The …
WEBSAN DIEGO, July 10, 2023 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host a Key Opinion Leader (KOL) webinar on August 8, 2023 at 12:00 pm Eastern Time, featuring presentations by KOLs Beverly MK Biller M.D. and Karen JP Liebert, R.N., BSN, both of Massachusetts General Hospital, who will discuss the …
Top Categories
Popular Searched
› Derby city council health issues
› Public health project coordinator
› Nj public health drinking water
› Providence health plan find providers
› Trinity health michigan application status
› Nuffield health pensions contact number
› Indian health service hr manual
Recently Searched
› Straits times health news today
› Central gippsland health service sale
› American indian health plan change form
› Adventhealth cfd north region
› Ghana health service statistics
› Heritage health elgin illinois